Search

Displaying results 1401 - 1410 of 5449 in total
  1. Drug

    Lomitapide

    go.drugbank.com/drugs/DB08827
    Approved

    Lomitapide, marketed under the brand names Juxtapid (USA) and Lojuxta (EU), is a first-in-class, small-molecule inhibitor of microsomal triglyceride transfer protein (MTP). … [A275445, A7367] This makes it a critical therapeutic option for "receptor-negative" patients who have little to no functional LDL receptor activity.

    Products: JUXTAPID® CÁPSULAS POR 20 MG, JUXTAPID® CÁPSULAS POR 5 MG
  2. Drug

    Ioversol

    go.drugbank.com/drugs/DB09134
    ApprovedInvestigational

    [L41780] Iodine has a high atomic density, which gives it the ability to attenuate X-rays. … [L41780] Ioversol was approved by the FDA in 1989 and is currently indicated for computed tomographic (CT) imaging and contrast enhancement in peripheral arteriography, coronary arteriography, and left

    Products: Optiray 240 mg J/ml - (nichtionische) parenterale Röntgenkontrastmittellösung, Optiray 300 mg J/ml - (nichtionische) parenterale Röntgenkontrastmittellösung
  3. Drug

    Bismuth subgallate

    go.drugbank.com/drugs/DB13909
    Approved

    internal deodorant where it is often employed as the primary active ingredient. … It is a heavy metal salt of gallic acid that is highly insoluble and poorly absorbed.

  4. Drug

    Mephentermine

    go.drugbank.com/drugs/DB01365
    ApprovedWithdrawn

    (From Martindale, The Extra Pharmacopoeia, 30th ed, p1248) … It is used to maintain blood pressure in hypotensive states, for example, following spinal anesthesia.

  5. Drug

    Midostaurin

    go.drugbank.com/drugs/DB06595
    ApprovedInvestigational

    It was initially characterized as a potential broad-spectrum antineoplastic agent, with activity toward diverse solid and hematopoietic tumors [A19108]. … It was approved on April 28, 2017 and has shown to increase the overall survival rate in patients with AML as an adjunct therapy along with chemotherapeutic agents.

    Products: RYDAPT (25 MG SOFT CAPSULES), RYDAPT 25 MG YUMUŞAK KAPSÜL, 112 ADET
  6. Drug

    Atractylodes lancea root oil

    go.drugbank.com/drugs/DB14338
    Approved

    It is not an approved drug.

    Mixtures: OHUI Sun Science Sun Block EX plus Beige
  7. Drug

    Dyphylline

    go.drugbank.com/drugs/DB00651
    ApprovedWithdrawn

    It is typically used in the management of asthma, cardiac dyspnea, and bronchitis.

    Mixtures: Dyphylline GG ESProducts: ASTMADIN 200 MG 150 ML SURUP, DIFILIN 400 MG SIMPLE TABLET, 20 TABLET
  8. Drug

    Dolasetron

    go.drugbank.com/drugs/DB00757
    ApprovedInvestigational

    This drug is not shown to have activity at other known serotonin receptors, and has low affinity for dopamine receptors.

    Products: Anzemet Injection 20 mg/ml
  9. Drug

    Silver nitrate

    go.drugbank.com/drugs/DB11080
    Approved

    It is often used as a precursor to other silver-containing compounds. … It is used in making photographic films, and in laboratory setting as a staining agent in protein visualization in PAGE gels and in scanning electron microscopy.

    Mixtures: Vet one
  10. Drug

    Anthralin

    go.drugbank.com/drugs/DB11157
    Approved

    It is important to consider that the drug is relatively innocuous, yet effective, and systemic side effects have not been observed with this anthralin, in contrast to a wide variety of systemic and topical … It is a main active ingredient in topical skin formulations for the treatment of psoriasis. Various formulations of the drug are available, including solutions, foams, and shampoos [L1979].